Nebulized resveratrol plus carboxymethyl-β-glucan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nebulized resveratrol plus carboxymethyl-β-glucan, covering 2019-12-05 to 2019-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis [Phase 4]